Medpace CEO sells 650 shares at $620 average
Medpace Holdings, Inc. (MEDP) reported that President & CEO August J. Troendle sold 650 shares of common stock on 2026-08-27 at a weighted average price of $620.27 per share in transactions effected pursuant to a limit order during an open window period.
Rhea-AI Filing Summary
Medpace Holdings, Inc. (MEDP) reported that President & CEO August J. Troendle sold 650 shares of common stock on 2026-08-27 at a weighted average price of $620.27 per share in transactions effected pursuant to a limit order during an open window period. After this sale, he directly holds 539,894 shares. He is also the sole manager and controlling unit holder of Medpace Investors, LLC, which holds 4,733,019 shares; he may be deemed to indirectly beneficially own those shares but disclaims beneficial ownership except to the extent of his pecuniary interest.
Positive
- None.
Negative
- None.
Insights
Analyzing...
Insider Trade Summary
Net Seller: 650 shares
Net Sell
2 txns
Insider
Troendle August J.
Role
President & CEO
Sold
650 shs ($403K)
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Sale | Common Stock F1, F2 | 650 | $620.27 | $403K |
| holding | Common Stock F3 | -- | -- | -- |
Holdings After Transaction:
Common Stock — 539,894 shares (Direct);
Common Stock — 4,733,019 shares (Indirect, By Medpace Investors, LLC)
Footnotes (3)
- F1. The transactions reported on this Form 4 were effected pursuant to a limit order placed by the Reporting Person during an open window period.
- F2. The reported price is a weighted average price. These shares were sold in multiple transactions ranging from $620.00 to $621.28. The Reporting Person undertakes to provide full pricing information to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission upon request.
- F3. The Reporting Person is the sole manager and controlling unit holder of Medpace Investors, LLC ("MPI") and has sole voting and investment control with respect to the securities held by MPI. The Reporting Person may be deemed to indirectly beneficially own the securities of the Issuer held by MPI but disclaims beneficial ownership of such securities except to the extent of his pecuniary interest therein.
Key Figures
Shares sold: 650 shares of Common Stock
Weighted average sale price: $620.27 per share
Direct holdings after transaction: 539,894 shares
+2 more
5 metrics
Shares sold
650 shares of Common Stock
Sale on 2026-08-27 by President & CEO August J. Troendle
Weighted average sale price
$620.27 per share
Weighted average for multiple sale transactions ranging from $620.00 to $621.28
Direct holdings after transaction
539,894 shares
Common Stock directly owned by August J. Troendle following the 2026-08-27 sale
Indirect holdings via Medpace Investors, LLC
4,733,019 shares
Common Stock held by Medpace Investors, LLC over which Troendle has sole voting and investment control
Net buy/sell shares
650 shares net sold
Net insider trading activity in this Form 4, classified as net-sell
Key Terms
limit order, weighted average price, indirectly beneficially own, pecuniary interest
4 terms
limit order market
"effected pursuant to a limit order placed by the Reporting Person"
A limit order is an instruction to buy or sell a stock only at a specific price or better, giving you control over the exact price you pay or receive. It matters to investors because it acts like a price guard—similar to setting a maximum you’ll pay for an item at a store—so you avoid unexpected prices, though the trade may not happen if the market never reaches your limit.
weighted average price financial
"The reported price is a weighted average price."
Weighted average price is the average price of a security where each trade or component is counted according to its size, so bigger trades pull the average more than smaller ones. Think of it like calculating the average cost of a grocery haul where items you bought more of have greater influence on the final per-item cost. Investors use it to understand the true average price paid or received, judge execution quality, and compare trading performance against market movement.
indirectly beneficially own financial
"may be deemed to indirectly beneficially own the securities"
pecuniary interest financial
"disclaims beneficial ownership of such securities except to the extent of his pecuniary interest"
FAQ
What insider transaction did MEDP report for August J. Troendle on this Form 4?
The filing reports that August J. Troendle sold 650 MEDP common shares on 2026-08-27 at a weighted average price of $620.27 per share in transactions effected under a limit order during an open window period.
What indirect MEDP holdings are associated with Medpace Investors, LLC?
Medpace Investors, LLC holds 4,733,019 MEDP shares. August J. Troendle is the sole manager and controlling unit holder, with sole voting and investment control, and may be deemed to indirectly beneficially own those shares while disclaiming beneficial ownership except for his pecuniary interest.
Was the MEDP insider sale made under a Rule 10b5-1 trading plan?
The Form 4 indicates the document-level Rule 10b5-1 checkbox is not marked. A footnote states the transactions were effected pursuant to a limit order placed during an open window period, not describing them as made under a Rule 10b5-1 plan.
AI-generated analysis. How Rhea-AI works. Not financial advice.
